Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis.
MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.
Deficits in medio-lateral balance control and the implications for falls in individuals with multiple sclerosis.
Antigen dynamics govern the induction of CD4(+) T cell tolerance during autoimmunity.
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Analyses on the misdiagnoses of 25 patients with unilateral optic nerve sheath meningioma.
Effect of interferon-β1α therapy on multiple sclerosis based on gadolinium-enhancing or active T2 magnetic resonance imaging outcomes: a meta-analysis.
Establishment of a rat model of chronic thoracolumbar cord compression with a flat plastic screw.
B Cell Malignancies Frequently Target the Autoreactive B Cell Repertoire.
Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
Regulating Axonal Responses to Injury: The Intersection between Signaling Pathways Involved in Axon Myelination and The Inhibition of Axon Regeneration.
Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts.
Simulations on the influence of myelin water in diffusion-weighted imaging.
Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
Risk of venous thromboembolism in neuromyelitis optica patients hospitalized for acute relapse.
Characterization of mouse spinal cord vascular network by means of synchrotron radiation X-ray phase contrast tomography.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Asturias and Cantabria].
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
Response on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.

Pages